858 Therapeutics

0 followers


858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response.

Industries

Headquarters

Stage

Employees

Links

Org chart

Jeffrey Stafford

Collapse
James Veal
Chief Scientific Officer
Sanjay Trehan
SVP, Business Development
Chris Mcbride
Sr. Director Of Medicinal Chemistry
Jane H.
Independent Board Director
Jim Veal
Chief Scientific Officer
Kimberly R.
Human Resources Director/Site Manager
Umi Chong
Sr. Director of Finance and Controller
Angie Vassar, M.S., PMP
Head of Program Management and Leadership